◀ Back to CCL22

CCL22 — TNFSF11

Text-mined interactions from Literome

Nakamura et al., Clin Exp Metastasis 2006 (Bone Neoplasms...) : RANKL induced CCL22/macrophage derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 ... CCL22 was selectively upregulated in osteoclast-like cells derived from RAW264.7 cells and mouse bone marrow cells upon stimulation with RANKL ( receptor activator of nuclear factor-kappaB ligand )
Meng et al., Placenta 2013 : Then BrdU cell proliferation assay, flow cytometry assay and ELISA were performed to investigate the effect of recombinant human RANKL and DSCs derived RANKL on the proliferation, apoptosis, chemokine (C-C motif) ligand 2 ( CCL2 ) secretion, C-C chemokine receptor type 2 ( CCR2 ) and other target proteins expression in DSCs in vitro, respectively